How does donating appreciated securities provide a double tax benefit compared to donating cash, and what are the limitations?
I'm reviewing CFA Level III wealth planning and my text mentions that donating appreciated stock to charity is more tax-efficient than donating cash. I understand you avoid capital gains tax on the appreciation, but is there also an income tax deduction? Can someone walk through the full tax benefit with actual numbers?
Donating appreciated securities to a qualified charity provides a double tax benefit: the donor (1) avoids capital gains tax on the unrealized appreciation and (2) receives an income tax deduction for the full fair market value. This makes it significantly more tax-efficient than selling the securities and donating the cash proceeds.\n\nThe Double Tax Benefit:\n\n| Benefit | Mechanism | Value |\n|---|---|---|\n| Avoid capital gains | No tax on unrealized appreciation | Saves LTCG rate x gain |\n| Income tax deduction | Deduct FMV from adjusted gross income | Saves marginal rate x FMV |\n\nSide-by-Side Comparison:\n\n`mermaid\ngraph TD\n A[\"Stock: FMV $100K
Cost basis $30K
Gain: $70K\"] --> B[\"Option A:
Donate Stock Directly\"]\n A --> C[\"Option B:
Sell Stock, Donate Cash\"]\n B --> D[\"No capital gains tax
Savings: $70K x 23.8% = $16,660\"]\n B --> E[\"Income tax deduction
$100K x 37% = $37,000\"]\n D --> F[\"Total tax benefit:
$16,660 + $37,000 = $53,660\"]\n C --> G[\"Pay capital gains tax
Cost: $70K x 23.8% = $16,660\"]\n C --> H[\"Cash after tax: $83,340
Donate $83,340\"]\n H --> I[\"Income tax deduction
$83,340 x 37% = $30,836\"]\n G --> J[\"Total tax benefit:
$30,836 - $16,660 = $14,176\"]\n`\n\nWorked Example:\nElderwood Philanthropic Advisors manages charitable giving for client Robert Ashworth. Robert is in the 37% federal income tax bracket and has accumulated $250,000 in Crestview Biotech shares purchased 4 years ago for $80,000 (current FMV: $250,000, unrealized LTCG: $170,000).\n\nRobert wants to donate $250,000 to the Ashworth Family Foundation.\n\nScenario A: Donate Crestview Biotech shares directly:\n- Capital gains tax avoided: $170,000 x 23.8% = $40,460\n- Income tax deduction: $250,000 x 37% = $92,500\n- Total tax benefit: $132,960\n- Effective cost of $250K donation: $250,000 - $132,960 = $117,040\n\nScenario B: Sell shares, donate cash:\n- Capital gains tax paid: $170,000 x 23.8% = $40,460\n- Cash after tax: $250,000 - $40,460 = $209,540\n- Robert adds $40,460 from other funds to donate the full $250,000\n- Income tax deduction: $250,000 x 37% = $92,500\n- Total tax benefit: $92,500 - $40,460 = $52,040\n- Effective cost: $250,000 - $52,040 = $197,960\n\nDonating shares saves Robert $132,960 - $52,040 = $80,920 compared to selling and donating cash.\n\nKey Limitations:\n\n1. Holding period: Securities must be held for more than one year. Short-term holdings are deductible only at cost basis, not FMV.\n2. AGI limits: Appreciated securities donations are limited to 30% of AGI (vs. 60% for cash). Excess can be carried forward 5 years.\n3. Private foundations: Donations of appreciated stock to private foundations are limited to 20% of AGI.\n4. AMT consideration: The unrealized gain may be an alternative minimum tax preference item for some taxpayers.\n5. Qualified appraisal: Donations of non-publicly-traded securities exceeding $5,000 require a qualified independent appraisal.\n\nPortfolio Integration:\n\nSmart wealth managers coordinate charitable giving with portfolio rebalancing — donating overweight, highly appreciated positions simultaneously achieves the philanthropic goal, the tax benefit, and portfolio rebalancing without triggering gains.\n\nExplore tax-efficient wealth transfer in our CFA Level III materials.
Master Level III with our CFA Course
107 lessons · 200+ hours· Expert instruction
Related Questions
What are the most reliable candlestick reversal patterns, and how should CFA candidates interpret them in context?
What are the CFA Standards requirements for research reports, and what must be disclosed versus recommended?
How does IAS 41 require biological assets to be measured, and what happens when fair value cannot be reliably determined?
Under IFRIC 12, how should a company account for a service concession arrangement, and what determines whether the intangible or financial asset model applies?
What is the investment entities exception under IFRS 10, and why are some parents exempt from consolidating their subsidiaries?
Join the Discussion
Ask questions and get expert answers.